- Country: Panama
- Summary: Rhea. 1000858581-06-03 Simvastatin, 10 Mg, Tablet Tablet, V.o.
- PAT Ref No: 70281182
- Deadline: 17 Aug 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: PAB 33750.00
- Notice Type: Tender
- Document Ref. No.: 2022-1-10-0-06-LP-472549
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Name of the Law: Req. 1000858581-06-03 Simvastatin, 10 mg, capsule or tablet, V.O.
Type of procedure: Law 51 - Social Security Fund
Description: Req. 1000858581-06-03 Simvastatin, 10 mg, capsule or tablet, V.O.
Publication date: 10-08-2022 02:19 pm
Date and time Presentation of proposals:
Date and time to open the proposal:
Place of presentation of proposals:
Remedy date:
Maximum date and time of reception of expressions of interest:
RECEPTION PLACE: DEPT. Of purchases coord. Adm. De Herrera
Reference price: 33750.00
Type_of_Award: Global - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINRhea. 1000858581-06-03 Simvastatin, 10 Mg, Tablet Tablet, V.o. - Panama Tender
The SOCIAL SECURITY FUND, a Government sector organization in Panama, has announced a new tender for Rhea. 1000858581-06-03 Simvastatin, 10 Mg, Tablet Tablet, V.o.. This tender is published on PanamaTenders under PAT Ref No: 70281182 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-08-17.
The estimated tender value is PAB 33750.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
